The EASEMENT study: A multicentre, observational, cross‐sectional study to evaluate patient preferences, treatment satisfaction, quality of life, and healthcare resource use in patients with multiple myeloma receiving injectable‐containing or fully oral therapies
European Journal of Haematology · 2024
DOI: 10.1111/ejh.14180 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Robert Ayto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Queen Alexandra Hospital, Portsmouth, UK. Hauptthemen laut MEDLINE: Multiple Myeloma, Quality of Life, Patient Preference, Patient Satisfaction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals, U.S.A., Inc., Lexington, MA, Takeda Pharmaceuticals International.
Abstract (Originalsprache)
Objective
As multiple myeloma (MM) therapies advance, understanding patients', caregivers', and physicians' perspectives on, and satisfaction with, available treatment options and their impact on quality of life (QoL), is important.
Methods
EASEMENT is a real‐world, observational, cross‐sectional study conducted in 19 sites within the UK, Canada, and Italy using retrospective chart reviews and surveys. Enrolled patients had clinical history available since diagnosis and had received ≥1 cycle of their current line of therapy. Primary objectives were to describe patient/caregiver QoL (EQ‐5D‐5L questionnaire), patient preference for oral/injectable therapies (single discrete‐choice question), and patient satisfaction (TSQM‐9 questionnaire).
Results
Between October 2018 and March 2020, 399 patients were enrolled ( n = 192 newly diagnosed multiple myeloma [NDMM], n = 206 relapsed/refractory multiple myeloma [RRMM], n = 1 missing). Among NDMM and RRMM patients, 78%/22% and 42%/58% were receiving injectables/orals, respectively. Both NDMM and RRMM patients significantly preferred orals versus injectables ( p < .0001). No significant differences were reported in treatment satisfaction or QoL, but treatment convenience favoured orals over injectables with near significance ( p = .053).
Conclusion
MM patients perceived greater convenience and preference for orals versus injectables. Oral treatments are useful for patients who cannot or prefer not to travel to clinics, or cannot perform self‐injection within the community.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Haematology, Queen Alexandra Hospital, Portsmouth, UK.
- Hematology, Stem Cell Transplantation, Fondazione Policlinico Universitario Campus Bio Medico di Roma, Rome, Italy.
- Medical Affairs, Europe & Canada, Takeda Pharmaceuticals International AG, Zurich, Switzerland.
- Real World Solutions, IQVIA, Barcelona, Spain.
- Medical Oncology & Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
ORCID-Profile: Robert Ayto, Ombretta Annibali, Patricia Biedermann, Montserrat Roset, Emilio Sánchez
Förderung
- Takeda Pharmaceuticals International AG
- Takeda Pharmaceuticals, U.S.A., Inc., Lexington, MA
- Takeda Pharmaceuticals International
Zitieren
APA
Ayto, R., Annibali, O., Biedermann, P., Roset, M., Sánchez, E., & Kotb, R. (2024). The EASEMENT study: A multicentre, observational, cross‐sectional study to evaluate patient preferences, treatment satisfaction, quality of life, and healthcare resource use in patients with multiple myeloma receiving injectable‐containing or fully oral therapies. European Journal of Haematology. https://doi.org/10.1111/ejh.14180
Vancouver
Ayto R, Annibali O, Biedermann P, Roset M, Sánchez E, Kotb R. The EASEMENT study: A multicentre, observational, cross‐sectional study to evaluate patient preferences, treatment satisfaction, quality of life, and healthcare resource use in patients with multiple myeloma receiving injectable‐containing or fully oral therapies. European Journal of Haematology. 2024. doi:10.1111/ejh.14180
BibTeX
@article{Ayto2024,
author = {Ayto, Robert and Annibali, Ombretta and Biedermann, Patricia and Roset, Montserrat and Sánchez, Emilio and Kotb, Rami},
title = {The EASEMENT study: A multicentre, observational, cross‐sectional study to evaluate patient preferences, treatment satisfaction, quality of life, and healthcare resource use in patients with multiple myeloma receiving injectable‐containing or fully oral therapies},
journal = {European Journal of Haematology},
year = {2024},
doi = {10.1111/ejh.14180}
}
EUVIMED